Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000150231 | SCV000197215 | likely benign | not specified | 2012-03-19 | criteria provided, single submitter | clinical testing | Pro59Pro in exon 1 of CASQ2: This variant is not expected to have clinical signi ficance because it does not alter an amino acid residue and is not located withi n the splice consensus sequence. It has been identified in 1/3738 African Americ an chromosomes from a broad population by the NHLBI Exome Sequencing Project (ht tp://evs.gs.washington.edu/EVS;rs371260149). Pro59Pro in exon 1 of CASQ2 (rs371 260149; allele frequency = 1/3738) ** |
Labcorp Genetics |
RCV002516018 | SCV000637644 | likely benign | Catecholaminergic polymorphic ventricular tachycardia 1 | 2025-01-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002399521 | SCV002713426 | likely benign | Cardiovascular phenotype | 2022-02-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV003338427 | SCV004048980 | likely benign | Catecholaminergic polymorphic ventricular tachycardia 2 | 2023-04-11 | criteria provided, single submitter | clinical testing |